What is Familial Alzheimer's disease?

Familial Alzheimer's disease (FAD) is a inherited form of dementia, which generally affects an individual 60 years of age and younger. Also known as Familial Alzheimer's disease (EOFAD) with early onset, individuals with genetic predisposition for this form of dementia develop gradually weakening symptoms that culminate in loss of cognitive function. In the absence of treatment, treatment of Familial Alzheimer's disease generally uses drugs to improve the quality of life of humans and slow down the progression of the disease.

There is no known, definitive cause of loss of cognitive function that is associated with the presence of Alzheimer's disease. Individuals with a family history of disorders generally begin to show symptoms and symptoms before reaching 60 years. Prominent genetic mutations of primary neurological proteins, including amyloid precursor protein (APP), were associated with the presence of familial Alzheimer's disease. Research has ALSO suggested that the development of Alzheimer may be associated with a combination of contributory factorů, including the environment and lifestyle.

individuals with genetic predisposition for the development of familial Alzheimer's disease often realize their situation, which is usually documented by their healthcare provider. The diagnosis of Alzheimer's disease is generally performed as soon as other conditions have been excluded that may disrupt one's knowledge. To evaluate the condition and functionality of the brain and control of abnormalities, such as lesions or tumors, imaging tests can be given. Blood tests are usually performed to reduce the presence of any disease or deficiency that can contribute to the symptoms of someone. Moreover, neuropsychological testing can be used to assess the cognitive abilities of a person, namely his memory, reasoning and thinking of skills.

Ti with the family of early boarding Alzheimer's disease can experience episodic confusion or worsening of memory in which wayIt is that they repeat or experience the inability to remember someone or an important date. As cognitive damage proceeds, it can place objects on unlikely or disproportionate places, they cannot remember the names of common items or even the names of close friends and relatives. Other signs of this weakening disease may include insomnia, agitation and anxiety. The progression of the disease generally requires continuous care of those who show the inability independently of themselves.

The treatment of familial Alzheimer's disease is generally focused on the treatment of symptoms and improves the quality of life. It is not uncommon to slow down the disease progression that drugs designed to improve neurological function, such as cholinesterase inhibitors, should be used. The establishment of routine, especially those that progress and mental activity and implementation of diet and lifestyle changes, are generally recommended that it helps to slow down the progression of symptoms. Individuals diagnosed with familial Alzheimer's disease, SPOlo with their families and carers are usually called to join a support group that supports FAD teaching and promotes healthy management of skills and friendships.